Ballerup, Denmark

Kristian Kjærgaard


 

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Kristian Kjærgaard: Innovator in Antibody Development

Introduction

Kristian Kjærgaard is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 5 patents, his work focuses on innovative solutions for inflammatory diseases.

Latest Patents

One of his latest patents is titled "Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity." This invention describes antibodies that specifically bind to and prevent the activation of TREM-1, a protein expressed on monocytes, macrophages, and neutrophils. These antibodies exhibit good affinity and low viscosity at clinically relevant concentrations, making them useful in treating individuals with inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

Another significant patent is "KIR-binding agents and methods of use thereof." This invention relates to agents and methods that enhance NK-mediated killing of target cells by reducing inhibitory KIR signaling without diminishing the binding of KIR to HLA-C. The patent discusses how transduction of negative signaling via KIR can lead to accelerated clustering, and it provides methods and agents, including monoclonal antibodies, to reduce KIR-mediated inhibition of NK cell cytotoxicity.

Career Highlights

Kristian Kjærgaard has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Innate Pharma S.A.S. His experience in these organizations has contributed to his expertise in antibody development and therapeutic applications.

Collaborations

Throughout his career, Kristian has collaborated with notable professionals in the field, including Søren Berg Padkær and Stefan Zahn. These collaborations have further enriched his research and innovation efforts.

Conclusion

Kristian Kjærgaard is a distinguished inventor whose work in antibody development has the potential to significantly impact the treatment of inflammatory diseases. His innovative patents and collaborations highlight his commitment to advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…